Compare CRNX & MHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRNX | MHF |
|---|---|---|
| Founded | 2008 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 150.1M |
| IPO Year | 2018 | N/A |
| Metric | CRNX | MHF |
|---|---|---|
| Price | $47.27 | $6.95 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $71.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 57.2K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.29% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,535,000.00 | N/A |
| Revenue This Year | $425.31 | N/A |
| Revenue Next Year | $943.50 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.74 | N/A |
| 52 Week Low | $24.10 | $5.92 |
| 52 Week High | $54.78 | $6.79 |
| Indicator | CRNX | MHF |
|---|---|---|
| Relative Strength Index (RSI) | 55.50 | 44.95 |
| Support Level | $43.04 | $6.88 |
| Resistance Level | $50.98 | $6.98 |
| Average True Range (ATR) | 2.29 | 0.08 |
| MACD | -0.22 | -0.00 |
| Stochastic Oscillator | 59.07 | 20.60 |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.